Key result
Oral inoculation with microencapsulated inactivated rotavirus induced virus-specific IgA in gut-associated lymphoid tissue, whereas unencapsulated virus did not.
Answers are grounded in this paper and cite their sources.
Microencapsulation may enhance oral rotavirus immunogenicity in animals; hypothesis-generating for human mucosal vaccines, with no practice change warranted.
The capacity of an aqueous-based system of microencapsulation to enhance virus-specific humoral immune responses was evaluated in mice orally inoculated with noninfectious rotavirus (simian rotavirus strain RRV). Mice were orally inoculated with 1.75 or 0.35 microgram of inactivated RRV (iRRV) or microencapsulated iRRV. Sera, intestinal contents, and organ cultures of gut-associated lymphoid tissues (GALT) were tested for the presence of rotavirus-specific antibodies. Virus-specific IgA was produced by small intestine lamina propria lymphocytes in animals inoculated with 1.75 or 0.35 microgram of microencapsulated virus, but not in mice inoculated with unencapsulated virus. Virus-specific IgA in sera and intestinal contents were not predictive of intestinal organ culture responses. Microencapsulation may be an efficient way of inducing virus-specific immune responses in GALT after oral inoculation with small quantities of viral antigen. In addition, delayed release of virus from microcapsules may obviate the need for booster immunizations.
No takes yet. Share an insight, caveat, or question.
Khoury et al. (1995) studied Rotavirus immunization. Microencapsulated inactivated rotavirus (iRRV) vs. Unencapsulated inactivated RRV was evaluated on Virus-specific IgA production by small intestine lamina propria lymphocytes. Oral inoculation with microencapsulated inactivated rotavirus induced virus-specific IgA in gut-associated lymphoid tissue, whereas unencapsulated virus did not.
Synapse has enriched 10 related papers. Consider them for comparative context: